Lymphocyte vitamin C levels as potential biomarker for progression of Parkinson's disease

Nutrition

Volumn 31, Issue 2, 2015, Pages 406-408

  Ide, Kazuki ^a   Yamada, Hiroshi ^a,b   Umegaki, Keizo ^c   Mizuno, Katsuki ^a   Kawakami, Nobuko ^b   Hagiwara, Yuka ^b   Matsumoto, Mizuki ^b   Yoshida, Hidefumi ^b   Kim, Kang ^b   Shiosaki, Emi ^b   Yokochi, Tsunehiro ^b   Harada, Kiyoshi ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b SHIZUOKA GENERAL HOSPITAL   (Japan)

^c NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

Author keywords

Biomarkers; Clinical assessment; Oxidative stress; Parkinson's disease; Vitamin C

Indexed keywords

ASCORBIC ACID; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HOEHN AND YAHR SCALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; VITAMIN BLOOD LEVEL; BLOOD; CHEMISTRY; DRUG EFFECTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ASCORBIC ACID; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 84920912040     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2014.08.001     Document Type: Article

References (20)

1. Jellinger K.A. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov Disord 2012, 27:8-30.
2. Halliday G.M., McCann H. The progression of pathology in Parkinson's disease. Ann N Y Acad Sci 2010, 1184:188-195.
3. Yürekli V.A., Gürler S., Naziroğlu M., Uğuz A.C., Koyuncuoğlu H.R. Zonisamide attenuates MPP+-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells. Cell Mol Neurobiol 2013, 33:205-212.
4. Kenae PC, Kurzawa M, Blain PG, Morris CM. Mitochondrial dysfunction in Parkinson's disease. Parkinson's Disease 2011. Available at: Accessed 2014 Sep4. http://dx.doi.org/10.4061/2011/716871.
5. Hwang O. Role of oxiadtive stress in Parkinson's disease. Exp Neurobiol 2013, 22:11-17.
6. Sharma S., Moon C.S., Khogali A., Haidous A., Chabenne A., Ojo C., et al. Biomarkers in Parkinson's disease (recent update). Neurochem Int 2013, 63:201-229.
7. Sato S., Mizuno Y., Hattori N. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease. Neurology 2005, 64:1081-1083.
8. Chen C.M., Liu J.L., Wu Y.R., Chen Y.C., Cheng H.S., Cheng M.L., et al. Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease. Neurobiol Dis 2009, 33:429-435.
9. King D., Playfer J.R., Roberts N.B. Concentrations of vitamins A, C and E in elderly patients with Parkinson's disease. Postgrad Med J 1992, 68:634-637.
10. Evans R.M., Currie L., Campbell A. The distribution of ascorbic acid between various cellular components of blood, in normal individuals, and its relation to the plasma concentration. Br J Nutr 1982, 47:473-482.
11. Wilson C.W. Clinical pharmacologic aspects of ascorbic acid. Ann N Y Acad Sci 1975, 258:355-376.
12. Yamada H., Yamada K., Waki M., Umegaki K. Lymphocyte and plasma vitamin C levels in type 2 diabetic patients with and without diabetes complications. Diabetes Care 2004, 27:2491-2492.
13. Grunewald R.A. Ascorbic acid in the brain. Brain Res Rev 1993, 18:123-133.
14. Ballaz S., Morales I., Rodriguez M., Obeso J.A. Ascorbate prevents cell death from prolonged exposure to glutamate in an invitro model of human dopaminergic neurons. J Neurosci Res 2013, 91:1609-1617.
15. Bagga V., Dunnett S.B., Fricker-Gates R.A. Ascorbic acid increases the number of dopamine neurons invitro and in transplants to the 6-OHDA-lesioned rat brain. Cell Transplant 2008, 17:763-773.
16. Harrison F.E., May J.M. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 2009, 46:719-730.
17. Umegaki K., Inoue K., Takeuchi N., Higuchi M. Improved method for the analysis of ascorbic acid in plasma by high-performance liquid chromatography with electrochemical detection. J Nutr Sci Vitaminol (Tokyo) 1994, 40:73-79.
18. Bowman G.L., Dodge H., Frei B., Calabrese C., Oken B.S., Kaye J.A., et al. Ascorbic acid and rates of cognitive decline in Alzheimer's disease. J Alzheimers Dis 2009, 16:93-98.
19. Shinde S., Pasupathy K. Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parinson's diease: preliminary study. Neurol India 2006, 54:390-393.
20. Rana M., de Coo I., Diaz F., Smeets H., Moraes C.T. An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann Neurol 2000, 48:774-781.